Pedro Horna

Associate Professor

Mayo Clinic Rochester

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pedro Horna is an Associate Professor at Mayo Clinic Rochester, USA. His research focuses on the application of flow cytometry in hematologic malignancies, with recent publications addressing plasma cell leukemia, chronic lymphocytic leukemia, and acute myeloid leukemia. He is involved in the clinical validation of innovative diagnostic approaches and the characterization of disease mechanisms in multiple myeloma and other blood cancers.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Collaborators (3)

Janosch Ortmann

Professor

University of Quebec

CANADA

View details

Martin Pule

University College London

UNITED KINGDOM

View details

S. Vincent Rajkumar

Professor of Medicine

Mayo Clinic Minnesota

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pedro Horna

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia

Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry

Measurable Residual Disease Analysis by Flow Cytometry: Assay Validation and Characterization of 385 Consecutive Cases of Acute Myeloid Leukemia

Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma

FDA IDE validation of multiple myeloma MRD test by flow cytometry

Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms

Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features

Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry

Iron-laden blasts in refractory acute myeloid leukemia

CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases

Collaborators (3)

Janosch Ortmann

Martin Pule

S. Vincent Rajkumar

Make your next move.